Mark H. Gotfried
Expertise in
2
conditions

Dr. Mark H. Gotfried

Pulmonary Medicine | Sleep Medicine
3811 E Bell Rd Ste 107, 
Phoenix, AZ 
 (1200.9 mi)
Accepting New Patients
Offers Telehealth
Expertise in
2
conditions
3811 E Bell Rd Ste 107, 
Phoenix, AZ 
 (1200.9 mi)
OverviewInsuranceLocationsClinical Research

Overview

Mark Gotfried is a Pulmonary Medicine specialist and a Sleep Medicine provider in Phoenix, Arizona. Dr. Gotfried is highly rated in 2 conditions, according to our data. His top areas of expertise are Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Nocardiosis, Excessive Daytime Sleepiness, and Endoscopy. Dr. Gotfried is currently accepting new patients.

His clinical research consists of co-authoring 41 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Sleep Medicine
Licenses
Internal Medicine in AZ
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Medica
  •  Oscar

Locations

3811 E Bell Rd Ste 107, Phoenix, AZ 85032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: January 17, 2023
Intervention Type: Drug
Study Phase: Phase 2
Double-Blind, Placebo-Controlled Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease
Double-Blind, Placebo-Controlled Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Drug
Study Drug: Trans Sodium Crocetinate
Study Phase: Phase 2
BIG4 - CPAP Educational Materials and Usage Feedback to Promote CPAP Adherence
BIG4 - CPAP Educational Materials and Usage Feedback to Promote CPAP Adherence
Enrollment Status: Completed
Publish Date: April 05, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase I Study to Determine and Compare Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Intravenous ETX2514 and Sulbactam Administered to Healthy Adult Subjects
A Phase I Study to Determine and Compare Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Intravenous ETX2514 and Sulbactam Administered to Healthy Adult Subjects
Enrollment Status: Completed
Publish Date: November 09, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

41 Total Publications

Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers.
Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers.
Journal: Antimicrobial agents and chemotherapy
Published: October 01, 2024
Similar Doctors
Expertise in
10
conditions
Dr. Kenneth S. Knox
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Expertise in
10
conditions
Dr. Kenneth S. Knox
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

Banner - University Physician Specialists LLC

755 E Mcdowell Rd, 
Phoenix, AZ 
 (11.6 mi)
602-521-3086
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kenneth Knox is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Phoenix, Arizona. Dr. Knox is highly rated in 10 conditions, according to our data. His top areas of expertise are Coccidioidomycosis, Sarcoidosis, Pneumonia, Acute Interstitial Pneumonia, and Lung Transplant. Dr. Knox is currently accepting new patients.

Expertise in
22
conditions
Dr. Rajat Walia
Pulmonary Medicine | Intensive Care Medicine
Expertise in
22
conditions
Dr. Rajat Walia
Pulmonary Medicine | Intensive Care Medicine

Sjhmc Physician Services

500 W Thomas Rd, 680 Dhmg St Joseph's Pelvic Pain And Surg, 
Phoenix, AZ 
 (11.0 mi)
602-406-6017
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rajat Walia is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Phoenix, Arizona. Dr. Walia is highly rated in 22 conditions, according to our data. His top areas of expertise are Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Lung Transplant, and Tissue Biopsy. Dr. Walia is currently accepting new patients.

Expertise in
6
conditions
Dr. Chad M. Ruoff
Sleep Medicine
Expertise in
6
conditions
Dr. Chad M. Ruoff
Sleep Medicine

Mayo Clinic Arizona

5779 E Mayo Blvd, Speciality Building, 
Phoenix, AZ 
 (3.5 mi)
480-301-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Chad Ruoff is a Sleep Medicine provider in Phoenix, Arizona. Dr. Ruoff is highly rated in 6 conditions, according to our data. His top areas of expertise are Drowsiness, Narcolepsy, Obstructive Sleep Apnea, and Excessive Daytime Sleepiness. Dr. Ruoff is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile